{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:35:23Z","timestamp":1790044523699,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009879","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T00:00:00Z","timestamp":1370390400000}}],"reference-count":35,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009879.pub2","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T13:50:25Z","timestamp":1370440225000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Slow-release oral morphine as maintenance therapy for opioid dependence"],"prefix":"10.1002","volume":"2013","author":[{"given":"Marica","family":"Ferri","sequence":"first","affiliation":[{"name":"European Monitoring Centre for Drugs and Drug Addiction; Interventions, Best Practice and Scientific Partners; Cais do Sodre' 1249-289 Lisbon Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Minozzi","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via di Santa Costanza, 53 Rome Italy 00198"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bo","sequence":"additional","affiliation":[{"name":"European Monitoring Centre for Drugs and Drug Addiction; Interventions, Best Practice and Scientific Partners; Cais do Sodre' 1249-289 Lisbon Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Amato","sequence":"additional","affiliation":[{"name":"Lazio Regional Health Service; Department of Epidemiology; Via di Santa Costanza, 53 Rome Italy 00198"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,6,5]]},"reference":[{"key":"10.1002\/14651858.CD009879.pub2-BIB0001|cit1","first-page":"S33","article-title":"A randomised trial of once-daily slow-release oral morphine versus methadone for heroin dependence","volume":"66 Suppl 1","author":"Clark","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1002\/14651858.CD009879.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1360-0443.2005.001128.x","article-title":"Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy","volume":"100","author":"Eder","year":"2005","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0003|cit3","first-page":"S42","article-title":"Methadone versus slow-relapse morphine maintenance for the treatment of opioid dependence","volume":"63 Suppl 1","author":"Eder","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1002\/14651858.CD009879.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000113724","article-title":"Quality of life in patients receiving opioid maintenance therapy. A comparative study of slow-release morphine versus methadone treatment","volume":"14","author":"Winklbaur","year":"2008","journal-title":"European Addiction Research"},{"issue":"2","key":"10.1002\/14651858.CD009879.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10826080500391845","article-title":"Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants","volume":"41","author":"Giacomuzzi","year":"2006","journal-title":"Substance Use and Misuse"},{"issue":"4","key":"10.1002\/14651858.CD009879.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1465-3362.2011.00353.x","article-title":"After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication","volume":"31","author":"Bond","year":"2012","journal-title":"Drug and Alcohol Review"},{"issue":"9","key":"10.1002\/14651858.CD009879.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1360-0443.2009.02653.x","article-title":"A double-blind, randomised, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification","volume":"104","author":"Madlung-Kratzer","year":"2009","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD009879.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(03)00190-X","article-title":"Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence","volume":"72","author":"Mitchell","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1002\/14651858.CD009879.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1360-0443.2004.00764.x","article-title":"Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence","volume":"99","author":"Mitchell","year":"2004","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/10550490600754374","article-title":"Switching between methadone and morphine for maintenance treatment of opioid dependence: impact on pain sensitivity and mood status","volume":"15","author":"Mitchell","year":"2006","journal-title":"American Journal on Addictions"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000259134","article-title":"Morphine maintenance treatment of opioid-dependent out-patients","volume":"2","author":"Moldovanyi","year":"1996","journal-title":"European Addiction Research"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0012|cit12","first-page":"35","article-title":"Oral morphine-sulfate in the treatment of opiate dependent patients","volume":"32","author":"Fischer","year":"1996","journal-title":"Alcoholism"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5694\/j.1326-5377.1996.tb124947.x","article-title":"Managing heroin addiction with a long-acting morphine product","volume":"165","author":"Sherman","year":"1996","journal-title":"The Medical Journal of Australia"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0014|cit14","unstructured":"Morphine Slow-release Capsules in Substitution Therapy Ongoing study October 2006"},{"issue":"10","key":"10.1002\/14651858.CD009879.pub2-BIB0015|cit15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004147","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009879.pub2-BIB0016|cit16","first-page":"108","article-title":"Impact of slow-release oral morphine on drug abusing habits in Austria","volume":"24","author":"Beer","year":"2010","journal-title":"Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater"},{"issue":"2","key":"10.1002\/14651858.CD009879.pub2-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002210","article-title":"LAAM maintenance vs methadone maintenance for heroin dependence","author":"Clark","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","article-title":"Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study","volume":"102","author":"Davoli","year":"2007","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0019|cit19","volume-title":"Annual Report. The State of Drugs Problem in Europe","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2011"},{"issue":"3","key":"10.1002\/14651858.CD009879.pub2-BIB0020|cit20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0021|cit21","first-page":"276","article-title":"Mortality of drug users attending public treatment centres in Italy 1998-2001: a cohort study","volume":"31","author":"Ferri","year":"2007","journal-title":"Epidemiologia e Prevenzione"},{"issue":"12","key":"10.1002\/14651858.CD009879.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003410","article-title":"Heroin maintenance for chronic heroin-dependent individuals","author":"Ferri","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"GRADE Working Group","year":"2004","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is 'quality of evidence' and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2010","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0026|cit26","unstructured":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention s Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD009879.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1365-2125.2011.03923.x","article-title":"Slow-release oral morphine for opioid maintenance treatment: a systematic review","volume":"71","author":"Jegu","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1111\/j.1360-0443.2008.02334.x","article-title":"Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression","volume":"103","author":"Kastelic","year":"2008","journal-title":"Addiction (Abingdon, England)"},{"issue":"2","key":"10.1002\/14651858.CD009879.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009879.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/rccm.200602-197ST","article-title":"An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations","volume":"174","author":"Sch\u00fcnemann","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009879.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/15622975.2011.561872","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: opioid dependence","volume":"12","author":"Soyka","year":"2011","journal-title":"The World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0033|cit33","volume-title":"World Drug Report","author":"United Nations Office on Drugs and Crime","year":"2011"},{"issue":"1","key":"10.1002\/14651858.CD009879.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1874473711205010003","article-title":"Evidence-based pharmacological treatment of substance use disorders and pathological gambling","volume":"5","author":"Brink","year":"2012","journal-title":"Current drug abuse reviews"},{"key":"10.1002\/14651858.CD009879.pub2-BIB0035|cit35","volume-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"World Health Organization","year":"2009"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009879.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T12:31:40Z","timestamp":1744115500000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009879.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,5]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009879.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,5]]}}}